Scientific Publications by FDA Staff

Retrovirology 2008 Feb 1;5:15

Hitting HIV where it hides.

Dayton AI

Dayton, AI (reprint author), OBRR CBER FDA, Div Emerging & Transfus Transmitted Dis, Lab Mol Virol, HFM 315,1401 Rockville Pike, Rockville, MD 20852 USA OBRR CBER FDA, Div Emerging & Transfus Transmitted Dis, Lab Mol Virol, Rockville, MD 20852 USA

The recent finding that inhibitors of PI3/Akt can sensitize HIV infected macrophages to oxidative stress-induced cell death suggest a potential new therapeutic approach to targeting HIV reservoirs.